| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1048 |
| Trial ID | ChiCTR-OIH-17012645 |
| Disease | B-Cell Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | BG-T19 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A clinical study of chimeric-antigen-receptor T cells in the treatment of chemo-refractory or relapsing leukemia |
| Year | 2017 |
| Country | China |
| Company sponsor | Pediatrics of Nanfang hospital |
| Cohort 1 | |||||||
|
|||||||